4.7 Review

Evaluation of human papilloma virus in semen as a risk factor for low sperm quality and poor in vitro fertilization outcomes: a systematic review and meta-analysis

期刊

FERTILITY AND STERILITY
卷 113, 期 5, 页码 955-+

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2020.01.010

关键词

Human papilloma virus; sperm analysis; in vitro fertilization outcomes; male infertility

向作者/读者索取更多资源

Objective: To analyze the effect of human papilloma virus (HPV) sperm infection on sperm parameters and in vitro fertilization (IVF) outcomes. Design: Systematic review and meta-analysis. Setting: Not applicable. Patients: Men with HPV sperm infection and couples undergoing IVF. Interventions: Searches were conducted in the following databases: Medline(R), PubMed, Embase, Web of Science, Scopos, and the Cochrane Library. We included studies examining sperm parameters and IVF results in patients with and without HPV sperm infection. Main Outcome Measures: Sperm analysis (concertation, count, volume, motility, morphology), according to the World Health Organization manual, pregnancy rate (PR), and miscarriage rate (MR). Results: Sixteen studies were included in this meta-analysis. The presence of HPV had a significant association with impaired sperm parameters in terms of concentration (mean difference (MD] 4.48, 95% confidence interval [CI] - 6.12 to 2.83), motility (MD - 11.71, 95% CI - 16.15 to 7.26), and morphology (MD 2.44, 95% CI 4.08 to 0.79. A review of the literature regarding ART outcomes showed an association between HPV infection and decreased PR, and an even stronger association between HPV infection and increased MR. Conclusion: Our meta-analysis shows a negative effect of HPV on sperm concentration, motility, and morphology. Further subgroup and categorical analysis confirmed the clinical significance of impaired sperm motility in HPV-infected sperm, although the sperm count and morphology must be carefully analyzed. The studies reviewed reported lower PR and increased MR in couples with HPV-infected sperm. As most studies had a moderate risk of bias, these observations warrant further large, well-designed studies before introducing clinical management recommendations. (C) 2020 by American Society for Reproductive Medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据